Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 388

1.

Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease.

Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Jon Møller H, Lorena Abate M, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E.

J Hepatol. 2019 Jul 10. pii: S0168-8278(19)30404-0. doi: 10.1016/j.jhep.2019.06.031. [Epub ahead of print]

PMID:
31301321
2.

Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study.

Eriksen PL, Thomsen KL, Larsen LP, Grønbaek H, Vilstrup H, Sørensen M.

Aliment Pharmacol Ther. 2019 Jul;50(1):84-92. doi: 10.1111/apt.15293. Epub 2019 May 17.

PMID:
31099410
3.

Cerebral water content mapping in cirrhosis patients with and without manifest HE.

Winterdahl M, Abbas Z, Noer O, Thomsen KL, Gras V, Nahimi A, Vilstrup H, Shah NJ, Dam G.

Metab Brain Dis. 2019 Aug;34(4):1071-1076. doi: 10.1007/s11011-019-00427-y. Epub 2019 May 14.

PMID:
31089866
4.

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?

Kornerup LS, Pflugrad H, Weissenborn K, Vilstrup H, Dam G.

Hepat Med. 2019 Mar 18;11:41-46. doi: 10.2147/HMER.S144667. eCollection 2019.

5.

Oral health and liver disease.

Grønkjaer LL, Vilstrup H.

Liver Int. 2019 May;39(5):995. doi: 10.1111/liv.14033. No abstract available.

PMID:
31020774
6.

Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.

Watson H, Guevara M, Vilstrup H, Ginès P.

J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683. [Epub ahead of print]

PMID:
30965392
7.

The liver-alpha cell axis and type 2 diabetes.

Wewer Albrechtsen NJ, Pedersen J, Galsgaard KD, Winther-Sørensen M, Suppli MP, Janah L, Gromada J, Vilstrup H, Knop FK, Holst JJ.

Endocr Rev. 2019 Mar 28. pii: er.2018-00251. doi: 10.1210/er.2018-00251. [Epub ahead of print]

PMID:
30920583
8.

Effects of implementation of a national fast track clinical pathway for hepatocellular carcinoma in Western Denmark.

Villadsen GE, Simonsen K, Ott P, Vilstrup H, Grønbæk H.

J Gastrointestin Liver Dis. 2019 Mar;28(1):83-88. doi: 10.15403/jgld.2014.1121.281.dnk.

9.

Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions.

Lykke Eriksen P, Sørensen M, Grønbæk H, Hamilton-Dutoit S, Vilstrup H, Thomsen KL.

Clin Res Hepatol Gastroenterol. 2019 Feb 13. pii: S2210-7401(19)30029-4. doi: 10.1016/j.clinre.2019.01.001. [Epub ahead of print]

PMID:
30770336
10.

Quality of life measures predict mortality in patients with cirrhosis and severe ascites.

Macdonald S, Jepsen P, Alrubaiy L, Watson H, Vilstrup H, Jalan R.

Aliment Pharmacol Ther. 2019 Feb;49(3):321-330. doi: 10.1111/apt.15084. Epub 2018 Dec 25.

PMID:
30585338
11.

Physical exercise for people with cirrhosis.

Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL.

Cochrane Database Syst Rev. 2018 Dec 21;12:CD012678. doi: 10.1002/14651858.CD012678.pub2.

PMID:
30575956
12.

MHE Testing in Real World Scenario.

Lauridsen MM, Vilstrup H.

J Clin Exp Hepatol. 2018 Dec;8(4):438-440. doi: 10.1016/j.jceh.2018.04.010. Epub 2018 May 5. Review.

PMID:
30564002
13.

Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites.

Bossen L, Ginès P, Vilstrup H, Watson H, Jepsen P.

J Gastroenterol Hepatol. 2019 May;34(5):914-920. doi: 10.1111/jgh.14558. Epub 2019 Jan 6.

PMID:
30500090
14.

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Kazankov K, Jørgensen SMD, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D, Grønbæk H.

Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159. doi: 10.1038/s41575-018-0082-x. Review.

PMID:
30482910
15.

Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.

Dam G, Vilstrup H, Andersen PK, Bossen L, Watson H, Jepsen P.

Liver Int. 2019 Mar;39(3):514-521. doi: 10.1111/liv.14012. Epub 2018 Dec 18.

PMID:
30472808
16.

Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated rats.

Aamann L, Ochoa-Sanchez R, Oliveira M, Tremblay M, Bémeur C, Dam G, Vilstrup H, Aagaard NK, Rose CF.

Liver Int. 2019 Apr;39(4):676-683. doi: 10.1111/liv.13997. Epub 2018 Nov 25.

PMID:
30394651
17.

Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis-Authors' reply.

Grønbaek L, Vilstrup H, Jepsen P.

Aliment Pharmacol Ther. 2018 Nov;48(9):1018-1019. doi: 10.1111/apt.14972. No abstract available.

PMID:
30318696
18.

Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis.

Eriksen PL, Hartkopf-Mikkelsen AL, Ott P, Vilstrup H, Aagaard NK.

United European Gastroenterol J. 2018 Oct;6(8):1199-1205. doi: 10.1177/2050640618781205. Epub 2018 May 28.

19.

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.

Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H.

Orphanet J Rare Dis. 2018 Sep 21;13(1):169. doi: 10.1186/s13023-018-0910-7.

20.

Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study.

Grønbaek L, Vilstrup H, Pedersen L, Jepsen P.

Liver Int. 2019 Jan;39(1):205-214. doi: 10.1111/liv.13963. Epub 2018 Oct 8.

PMID:
30218621

Supplemental Content

Loading ...
Support Center